跳至主要内容
临床试验/NCT06454097
NCT06454097招募中不适用

Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas

Beijing Tiantan Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年1月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
Sensitivity of the AI model in predicting radiochemotherapy respone

研究概览

简要总结

The MRI data were collected from patients with gliomas before surgery, 2 weeks before initiating radiochemotherapy, 1 month after completing the radiotherapy (for lower-grade gliomas, LGG), or 4 and 10 months after completing the radiochemotherapy (for high-grade gliomas, HGG). Radiochemotherapy sensitivity labels were constructed based on the MRI images obtained before and after radiochemotherapy, following the RANO criteria. Radiomics features were extracted from preoperative MRI images and combined with transcriptomic information obtained from tumor tissue sequencing. This process allowed the construction of a radiogenomics model capable of predicting the response of gliomas to radiochemotherapy.

In this prospective cohort study, we will recruit patients with gliomas who have undergone craniotomy and received postoperative radiotherapy or radiochemotherapy (in cases of LGG and HGG, respectively). MRI images of the same sequences will be collected at corresponding time points, and transcriptomic sequencing will be performed on tumor tissue obtained during surgery. The established model will be applied to predict radiochemotherapy sensitivity and compared with the 'true' radiochemotherapy sensitivity labels, which are constructed based on the RANO criteria, to evaluate the predictive performance of the model.

详细描述

This trial aims to recruit 100 cases of LGG and 100 cases of HGG based on statistical calculations. MRI data, including T1-weighted, T2-weighted, T1 contrast-enhanced, and T2-Fluid Attenuated Inversion Recovery (FLAIR) sequences, will be collected before surgery, 2 weeks before initiating radiochemotherapy, 1 month after completing the radiotherapy (LGG), or 4 and 10 months after completing the radiochemotherapy (HGG).

The collected MRI images before and after radiochemotherapy will be used to assess changes in tumor volume. The RANO criteria will be employed to determine the tumor's sensitivity to radiochemotherapy: a complete response and partial response will be classified as sensitive, while stable disease and disease progression will be considered insensitive.

Radiomics features will be extracted using the open-source 'PyRadiomics' python package after performing image preprocessing and segmentation. Transcriptomic data will be obtained by conducting RNA sequencing analysis on tumor samples collected during surgery. Selected radiogenomic features will be incorporated into a pre-constructed machine learning model to predict the sensitivity of gliomas to radiochemotherapy. The model's performance will be evaluated using metrics such as classification accuracy (ACC), area under the receiver operating characteristic curve (AUC), positive predictive value (PPV), and negative predictive value (NPV).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 or older
  • Histologically confirmed glioma
  • No history of other brain tumors or previous cranial surgeries
  • No history of preoperative radiotherapy or chemotherapy
  • Available preoperative, pre-radiotherapy(postoperatively), and post-radiotherapy magnetic resonance imaging (MRI) data

排除标准

  • Those who do not meet any of the inclusion criteria

结局指标

主要结局

Sensitivity of the AI model in predicting radiochemotherapy respone

时间窗: 1 month after radiotherapy (LGG); 4 and 10 months after radiochemotherapy (HGG)

Sensitivity = TP/(TP+FN)

Specificity of the AI model in predicting radiochemotherapy respone

时间窗: 1 month after radiotherapy (LGG); 4 and 10 months after radiochemotherapy (HGG)

Specificity = TN/(TN+FP)

Area under the Receiver Operating Characteristic curve (AUC)

时间窗: 1 month after radiotherapy (LGG); 4 and 10 months after radiochemotherapy (HGG)

AUC measures the entire two-dimensional area underneath the entire ROC curve

次要结局

  • Accuracy of the AI model in predicting radiochemotherapy respone(1 month after radiotherapy (LGG); 4 and 10 months after radiochemotherapy (HGG))
  • Negative predictive value (NPV) of the AI model in predicting radiochemotherapy respone(1 month after radiotherapy (LGG); 4 and 10 months after radiochemotherapy (HGG))
  • Positive predictive value (PPV) of the AI model in predicting radiochemotherapy respone(1 month after radiotherapy (LGG); 4 and 10 months after radiochemotherapy (HGG))

研究者

发起方
Beijing Tiantan Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验